These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
151 related items for PubMed ID: 17038964
1. Measurement of microbicide acceptability among U.S. adolescent girls. Short MB, Perfect MM, Auslander BA, Devellis RF, Rosenthal SL. Sex Transm Dis; 2007 Jun; 34(6):362-6. PubMed ID: 17038964 [Abstract] [Full Text] [Related]
2. Predictors of using a microbicide-like product among adolescent girls. Short MB, Succop PA, Ugueto AM, Rosenthal SL. J Adolesc Health; 2007 Oct; 41(4):357-62. PubMed ID: 17875461 [Abstract] [Full Text] [Related]
5. Acceptability of a non-woven device for vaginal drug delivery of microbicides or other active agents. Joanis CL, Hart CW. AIDS Behav; 2010 Jun; 14(3):600-6. PubMed ID: 20049522 [Abstract] [Full Text] [Related]
6. Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: results of product trials in three cities. Hammett TM, Mason TH, Joanis CL, Foster SE, Harmon P, Robles RR, Finlinson HA, Feudo R, Vining-Bethea S, Jeter G, Mayer KH, Doherty-Iddings P, Seage GR. Sex Transm Dis; 2000 Feb; 27(2):119-26. PubMed ID: 10676980 [Abstract] [Full Text] [Related]
7. Adolescents' descriptions of the physical characteristics of microbicide surrogates and experiences of use. Zubowicz EA, Oakes JK, Short MB, Perfect MM, Succop PS, Rosenthal SL. J Womens Health (Larchmt); 2006 Oct; 15(8):952-61. PubMed ID: 17087619 [Abstract] [Full Text] [Related]
8. Desired qualities and hypothetical contextual use of vaginal microbicides in a diverse sample of US women. Olsen ML, Cwiak CA, Koudelka C, Jensen JT. Contraception; 2007 Oct; 76(4):314-8. PubMed ID: 17900444 [Abstract] [Full Text] [Related]
9. Challenges of introducing vaginal microbicides in India. Joshi S, Kulkarni V, Paranjape R, Chandhiok N. Indian J Med Res; 2009 May; 129(5):618-9. PubMed ID: 19675395 [No Abstract] [Full Text] [Related]
10. Differentiating normal from abnormal rates of genital epithelial findings in vaginal microbicide trials. van de Wijgert JH, Kilmarx PH, Jones HE, Karon JM, Chaikummao S. Contraception; 2008 Feb; 77(2):122-9. PubMed ID: 18226677 [Abstract] [Full Text] [Related]
11. Young women's use of a vaginal microbicide surrogate: the role of individual and contextual factors in acceptability and sexual pleasure. Tanner AE, Zimet G, Fortenberry JD, Reece M, Graham C, Murray M. J Sex Res; 2009 Feb; 46(1):15-23. PubMed ID: 19012060 [Abstract] [Full Text] [Related]
12. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial. Morrow K, Rosen R, Richter L, Emans A, Forbes A, Day J, Morar N, Maslankowski L, Profy AT, Kelly C, Abdool Karim SS, Mayer KH. J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106 [Abstract] [Full Text] [Related]